Revenio Group Oyj — Director's Dealing 2022

Feb 17, 2022

REVENIO

Revenio Group Corporation: Managers' Transactions - Barbaro Giuliano

Revenio Group Corporation, Managers' transactions, February 17, 2022 at 4.30 p.m. (EET)

Revenio Group Corporation: Managers' Transactions – Barbaro Giuliano

Issuer: Revenio Group Oyj
LEI: 743700127E0FWSXLKK04
Notification type: INITIAL NOTIFICATION
Reference number: 10282/4/6

Transaction date: 2022-02-14
Venue not applicable
Instrument type: SHARE
ISIN: F10009010912
Nature of the transaction: RECEIPT OF A SHARE-BASED INCENTIVE

Transaction details
(1): Volume: 2203 Unit price:
Aggregated transactions
(1): Volume: 2203 Volume weighted average price:

For further information, please contact:
CFO Robin Pulkkinen, tel. +358 50 505 9932
robin.pulkkinen@revenio.fi
www.revenio.fi

DISTRIBUTION:
Nasdaq Helsinki Ltd
Main media
www.revenio.fi

Revenio Group in brief

Revenio is a leading company in the global market for ophthalmological devices and software solutions. Revenio's ophthalmic diagnostic solutions include intraocular pressure (IOP) measurement devices (tonometers), perimeter and fundus imaging devices under the iCare brand. In addition, the Group's eye care software platform Oculo offers clinical communication, telehealth, remote patient monitoring and data analytics capabilities.

Revenio Group
Àyritie 22
FI-01510 Vantaa

---

REVENIO

In 2021, the Group's net sales totaled EUR 78.8 million, with an operating profit of EUR 22.1 million. Revenio Group Corporation is listed on Nasdaq Helsinki with the trading code REG1V.

Attachments

Revenio Group Corporation: Managers' Transactions – Barbaro Giuliano

Revenio Group | Äyritie 22 | FI-01510 Vantaa